Lapatinib potentiates cytotoxicity of YM155 in neuroblastoma via inhibition of the ABCB1 efflux transporter
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lapatinib potentiates cytotoxicity of YM155 in neuroblastoma via inhibition of the ABCB1 efflux transporter
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-06-02
DOI
10.1038/s41598-017-03129-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ABC drug transporter gene expression in neuroblastoma.
- (2017) S. Cialfi et al. JOURNAL OF CLINICAL ONCOLOGY
- A multicenter phase II study of sepantronium bromide (YM155) plus rituximab in patients with relapsed aggressive B-cell Non-Hodgkin lymphoma
- (2016) Kyriakos P. Papadopoulos et al. LEUKEMIA & LYMPHOMA
- Integrating network reconstruction with mechanistic modeling to predict cancer therapies
- (2016) M. Halasz et al. Science Signaling
- Integrating network reconstruction with mechanistic modeling to predict cancer therapies
- (2016) M. Halasz et al. Science Signaling
- YM155 potently kills acute lymphoblastic leukemia cells through activation of the DNA damage pathway
- (2015) Bill H Chang et al. Journal of Hematology & Oncology
- Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patients
- (2015) D. Fey et al. Science Signaling
- Temporal proteomics of NGF-TrkA signaling identifies an inhibitory role for the E3 ligase Cbl-b in neuroblastoma cell differentiation
- (2015) K. B. Emdal et al. Science Signaling
- Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patients
- (2015) D. Fey et al. Science Signaling
- Temporal proteomics of NGF-TrkA signaling identifies an inhibitory role for the E3 ligase Cbl-b in neuroblastoma cell differentiation
- (2015) K. B. Emdal et al. Science Signaling
- The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity
- (2014) Georg E Winter et al. Nature Chemical Biology
- Mechanisms of neuroblastoma regression
- (2014) Garrett M. Brodeur et al. Nature Reviews Clinical Oncology
- A phase 2, multicenter, open-label study of sepantronium bromide (YM155) plus docetaxel in patients with stage III (unresectable) or stage IV melanoma
- (2014) Ragini Kudchadkar et al. Cancer Medicine
- Multidrug Resistance and Cancer Stem Cells in Neuroblastoma and Hepatoblastoma
- (2013) Anna Alisi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A molecular biology and phase II trial of lapatinib in children with refractory CNS malignancies: a pediatric brain tumor consortium study
- (2013) Maryam Fouladi et al. JOURNAL OF NEURO-ONCOLOGY
- Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study
- (2013) Gemma Gatta et al. LANCET ONCOLOGY
- Activated ALK Collaborates with MYCN in Neuroblastoma Pathogenesis
- (2012) Shizhen Zhu et al. CANCER CELL
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas
- (2012) Matthias A. Karajannis et al. NEURO-ONCOLOGY
- Utility of P-Glycoprotein and Organic Cation Transporter 1 Double-Transfected LLC-PK1 Cells for Studying the Interaction of YM155 Monobromide, Novel Small-Molecule Survivin Suppressant, with P-Glycoprotein
- (2011) M. Iwai et al. DRUG METABOLISM AND DISPOSITION
- Targeted BIRC5 silencing using YM155 causes cell death in neuroblastoma cells with low ABCB1 expression
- (2011) Fieke Lamers et al. EUROPEAN JOURNAL OF CANCER
- An Integrated Chemical Biology Approach Identifies Specific Vulnerability of Ewing's Sarcoma to Combined Inhibition of Aurora Kinases A and B
- (2011) G. E. Winter et al. MOLECULAR CANCER THERAPEUTICS
- Direct and Coordinate Regulation of ATP-binding Cassette Transporter Genes by Myc Factors Generates Specific Transcription Signatures That Significantly Affect the Chemoresistance Phenotype of Cancer Cells
- (2010) Antonio Porro et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First Century
- (2010) Malcolm A. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Trk Receptor Expression and Inhibition in Neuroblastomas
- (2009) G. M. Brodeur et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now